Trade Laboratory Corprtn Of Amer Holdings - LH CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.46 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Laboratory Corporation of America Holdings ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 205.25 |
| Open* | 205.65 |
| 1-Year Change* | -2.33% |
| Day's Range* | 203.81 - 205.93 |
| 52 wk Range | 172.09-222.41 |
| Average Volume (10 days) | 835.09K |
| Average Volume (3 months) | 15.29M |
| Market Cap | 18.19B |
| P/E Ratio | 23.12 |
| Shares Outstanding | 88.60M |
| Revenue | 14.09B |
| EPS | 8.88 |
| Dividend (Yield %) | 1.40317 |
| Beta | 1.08 |
| Next Earnings Date | Oct 25, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 26, 2023 | 205.25 | -1.16 | -0.56% | 206.41 | 208.56 | 205.13 |
| Sep 25, 2023 | 208.23 | 4.86 | 2.39% | 203.37 | 208.43 | 203.36 |
| Sep 22, 2023 | 205.09 | 1.61 | 0.79% | 203.48 | 206.71 | 203.39 |
| Sep 21, 2023 | 205.05 | 2.35 | 1.16% | 202.70 | 207.35 | 202.69 |
| Sep 20, 2023 | 205.04 | 1.21 | 0.59% | 203.83 | 206.22 | 202.09 |
| Sep 19, 2023 | 204.50 | 5.34 | 2.68% | 199.16 | 204.83 | 199.16 |
| Sep 18, 2023 | 201.03 | 0.92 | 0.46% | 200.11 | 202.00 | 197.71 |
| Sep 15, 2023 | 201.50 | 0.24 | 0.12% | 201.26 | 204.30 | 201.05 |
| Sep 14, 2023 | 203.53 | -1.41 | -0.69% | 204.94 | 206.33 | 203.11 |
| Sep 13, 2023 | 204.43 | 3.81 | 1.90% | 200.62 | 204.63 | 199.49 |
| Sep 12, 2023 | 201.54 | 0.83 | 0.41% | 200.71 | 203.37 | 200.54 |
| Sep 11, 2023 | 201.84 | 0.82 | 0.41% | 201.02 | 204.24 | 201.01 |
| Sep 8, 2023 | 203.23 | 0.55 | 0.27% | 202.68 | 205.19 | 202.56 |
| Sep 7, 2023 | 205.18 | 2.68 | 1.32% | 202.50 | 205.37 | 202.50 |
| Sep 6, 2023 | 204.46 | 2.17 | 1.07% | 202.29 | 204.86 | 200.69 |
| Sep 5, 2023 | 204.27 | -0.35 | -0.17% | 204.62 | 205.56 | 200.93 |
| Sep 1, 2023 | 206.34 | -0.94 | -0.45% | 207.28 | 209.63 | 205.61 |
| Aug 31, 2023 | 207.95 | -2.44 | -1.16% | 210.39 | 213.16 | 207.53 |
| Aug 30, 2023 | 212.26 | 1.79 | 0.85% | 210.47 | 212.82 | 209.54 |
| Aug 29, 2023 | 211.20 | 0.38 | 0.18% | 210.82 | 212.25 | 209.95 |
Laboratory Corprtn Of Amer Holdings Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, October 25, 2023 | ||
| Time (UTC) 12:30 | Country US
| Event Q3 2023 Laboratory Corporation of America Holdings Earnings Release Q3 2023 Laboratory Corporation of America Holdings Earnings ReleaseForecast -Previous - |
| Wednesday, February 14, 2024 | ||
| Time (UTC) 13:30 | Country US
| Event Q4 2023 Laboratory Corporation of America Holdings Earnings Release Q4 2023 Laboratory Corporation of America Holdings Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 14876.8 | 16120.9 | 13978.5 | 11554.8 | 11333.4 |
| Revenue | 14876.8 | 16120.9 | 13978.5 | 11554.8 | 11333.4 |
| Cost of Revenue, Total | 10491.7 | 10496.6 | 9025.7 | 8302.3 | 8157 |
| Gross Profit | 4385.1 | 5624.3 | 4952.8 | 3252.5 | 3176.4 |
| Total Operating Expense | 13102.9 | 12867.6 | 11475.6 | 10229.8 | 10007.7 |
| Selling/General/Admin. Expenses, Total | 1996.6 | 1898.8 | 1674.7 | 1523.5 | 1570.9 |
| Depreciation / Amortization | 259.3 | 369.6 | 275.4 | 243.2 | 231.7 |
| Unusual Expense (Income) | 355.3 | 102.6 | 499.8 | 160.8 | 48.1 |
| Operating Income | 1773.9 | 3253.3 | 2502.9 | 1325 | 1325.7 |
| Interest Income (Expense), Net Non-Operating | -190.6 | -118 | -204.3 | -212.3 | -225.1 |
| Other, Net | -0.7 | -8.7 | -79.5 | -7.8 | 167.7 |
| Net Income Before Taxes | 1582.6 | 3126.6 | 2219.1 | 1104.9 | 1268.3 |
| Net Income After Taxes | 1280.6 | 2379.5 | 1557 | 824.9 | 928.8 |
| Minority Interest | -1.5 | -2.2 | -0.9 | -1.1 | -0.2 |
| Net Income Before Extra. Items | 1279.1 | 2377.3 | 1556.1 | 823.8 | 928.6 |
| Net Income | 1279.1 | 2377.3 | 1556.1 | 823.8 | 883.7 |
| Income Available to Common Excl. Extra. Items | 1279.1 | 2377.3 | 1556.1 | 823.8 | 928.6 |
| Income Available to Common Incl. Extra. Items | 1279.1 | 2377.3 | 1556.1 | 823.8 | 883.7 |
| Diluted Net Income | 1279.1 | 2377.3 | 1556.1 | 823.8 | 883.7 |
| Diluted Weighted Average Shares | 91.6 | 97.5 | 98 | 98.6 | 102.6 |
| Diluted EPS Excluding Extraordinary Items | 13.964 | 24.3826 | 15.8786 | 8.35497 | 9.05068 |
| Diluted Normalized EPS | 17.1026 | 25.1834 | 19.4569 | 9.57252 | 10.2348 |
| Total Extraordinary Items | -44.9 | ||||
| Dividends per Share - Common Stock Primary Issue | 2.16 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 3033.7 | 3777.9 | 3674.2 | 3606.1 | 2923 |
| Revenue | 3033.7 | 3777.9 | 3674.2 | 3606.1 | 2923 |
| Cost of Revenue, Total | 2191.5 | 2803.2 | 2704.4 | 2546.4 | 1980.5 |
| Gross Profit | 842.2 | 974.7 | 969.8 | 1059.7 | 942.5 |
| Total Operating Expense | 2767.4 | 3436.9 | 3583.5 | 3136.7 | 2494.2 |
| Selling/General/Admin. Expenses, Total | 505.8 | 553.6 | 536.5 | 510 | 432.4 |
| Depreciation / Amortization | 51.5 | 69.3 | 60.6 | 65.2 | 49.8 |
| Unusual Expense (Income) | 18.6 | 10.8 | 282 | 15.1 | 31.5 |
| Operating Income | 266.3 | 341 | 90.7 | 469.4 | 428.8 |
| Interest Income (Expense), Net Non-Operating | -59.7 | -55 | -87.6 | -33.4 | -68.9 |
| Other, Net | -1.6 | -8.2 | 41.4 | -14.4 | 0.2 |
| Net Income Before Taxes | 205 | 277.8 | 44.5 | 421.6 | 360.1 |
| Net Income After Taxes | 155.2 | 213.3 | 76.4 | 353.2 | 268 |
| Minority Interest | -0.2 | -0.4 | -0.3 | -0.4 | -0.3 |
| Net Income Before Extra. Items | 155 | 212.9 | 76.1 | 352.8 | 267.7 |
| Net Income | 188.9 | 212.9 | 76.1 | 352.8 | 358.6 |
| Income Available to Common Excl. Extra. Items | 155 | 212.9 | 76.1 | 352.8 | 267.7 |
| Income Available to Common Incl. Extra. Items | 188.9 | 212.9 | 76.1 | 352.8 | 358.6 |
| Diluted Net Income | 188.9 | 212.9 | 76.1 | 352.8 | 358.6 |
| Diluted Weighted Average Shares | 89 | 89 | 89.2 | 90.7 | 92.7 |
| Diluted EPS Excluding Extraordinary Items | 1.74157 | 2.39213 | 0.85314 | 3.88975 | 2.88781 |
| Dividends per Share - Common Stock Primary Issue | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
| Diluted Normalized EPS | 1.89979 | 2.48531 | 2.90807 | 4.02922 | 3.14071 |
| Total Extraordinary Items | 33.9 | 90.9 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 4625 | 5330.5 | 5125.4 | 2981.2 | 2835.4 |
| Cash and Short Term Investments | 430 | 1472.7 | 1320.8 | 337.5 | 426.8 |
| Cash & Equivalents | 430 | 1472.7 | 1320.8 | 337.5 | 426.8 |
| Total Receivables, Net | 3017.4 | 2978.3 | 3016.6 | 2025.3 | 1862.3 |
| Accounts Receivable - Trade, Net | 3017.4 | 2978.3 | 3016.6 | 2025.3 | 1862.3 |
| Total Inventory | 470.6 | 401.4 | 423.2 | 244.7 | 237.3 |
| Prepaid Expenses | 707 | 478.1 | 364.8 | 373.7 | 309 |
| Total Assets | 20155.1 | 20385.4 | 20071.7 | 18046.4 | 16185.3 |
| Property/Plant/Equipment, Total - Net | 3031.1 | 2897.1 | 2809.3 | 2724.3 | 1784.7 |
| Property/Plant/Equipment, Total - Gross | 5753.9 | 5310.3 | 5012.4 | 4653 | 3557.6 |
| Accumulated Depreciation, Total | -2722.8 | -2413.2 | -2203.1 | -1928.7 | -1772.9 |
| Goodwill, Net | 8121 | 7958.9 | 7751.5 | 7865 | 7360.3 |
| Intangibles, Net | 3946.9 | 3735.5 | 3961.1 | 4034.5 | 3911.1 |
| Long Term Investments | 65.7 | 60.9 | 73.5 | 84.9 | 60.5 |
| Other Long Term Assets, Total | 365.4 | 402.5 | 350.9 | 356.5 | 233.3 |
| Total Current Liabilities | 3078.5 | 2782.9 | 3078.5 | 2655.8 | 1878.9 |
| Accounts Payable | 934.8 | 621.3 | 638.9 | 632.3 | 634.6 |
| Accrued Expenses | 1108.2 | 1351.5 | 1174.9 | 992.2 | 704.8 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 8.2 |
| Current Port. of LT Debt/Capital Leases | 307.3 | 12 | 383.4 | 423.6 | 9.7 |
| Other Current Liabilities, Total | 728.2 | 798.1 | 881.3 | 607.7 | 521.6 |
| Total Liabilities | 10058.5 | 10112 | 10712 | 10479.4 | 9213.9 |
| Total Long Term Debt | 5122.4 | 5501.1 | 5503.4 | 5880.9 | 6041.9 |
| Long Term Debt | 5038.8 | 5416.5 | 5419 | 5789.8 | 5990.9 |
| Capital Lease Obligations | 83.6 | 84.6 | 84.4 | 91.1 | 51 |
| Deferred Income Tax | 736.2 | 762.9 | 905.4 | 942.8 | 940 |
| Minority Interest | 18.9 | 20.6 | 20.7 | 20.1 | 19.1 |
| Other Liabilities, Total | 1102.5 | 1044.5 | 1204 | 979.8 | 334 |
| Total Equity | 10096.6 | 10273.4 | 9359.7 | 7567 | 6971.4 |
| Common Stock | 8.1 | 8.5 | 9 | 9 | 11.7 |
| Additional Paid-In Capital | 0 | 110.3 | 26.8 | 1451.1 | |
| Retained Earnings (Accumulated Deficit) | 10581.7 | 10456.8 | 9402.3 | 7903.6 | 7079.8 |
| Treasury Stock - Common | 0 | -1108.1 | |||
| Unrealized Gain (Loss) | |||||
| Other Equity, Total | -493.2 | -191.9 | -161.9 | -372.4 | -463.1 |
| Total Liabilities & Shareholders’ Equity | 20155.1 | 20385.4 | 20071.7 | 18046.4 | 16185.3 |
| Total Common Shares Outstanding | 88.2 | 93.1 | 97.5 | 97.2 | 98.9 |
| Other Current Assets, Total | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 4695 | 4625 | 4371.8 | 5030.8 | 5229.5 |
| Cash and Short Term Investments | 393.9 | 430 | 409.9 | 1068.8 | 1233.5 |
| Cash & Equivalents | 393.9 | 430 | 409.9 | 1068.8 | 1233.5 |
| Total Receivables, Net | 3049.9 | 3017.4 | 2982.7 | 3043.8 | 3039.6 |
| Accounts Receivable - Trade, Net | 3049.9 | 3017.4 | 2982.7 | 3043.8 | 3039.6 |
| Total Inventory | 481.4 | 470.6 | 467.7 | 436.3 | 440.7 |
| Prepaid Expenses | 769.8 | 707 | 511.5 | 481.9 | 515.7 |
| Total Assets | 20200 | 20155.1 | 19826 | 20403.1 | 20728.4 |
| Property/Plant/Equipment, Total - Net | 2944.1 | 2956.2 | 2884.7 | 2870.2 | 2807.6 |
| Goodwill, Net | 8116 | 8121 | 8217.6 | 8114 | 8165.8 |
| Intangibles, Net | 3912.3 | 3946.9 | 3807.8 | 3864.9 | 3972.5 |
| Long Term Investments | 65.8 | 65.7 | 63.7 | 57.7 | 62.2 |
| Other Long Term Assets, Total | 466.8 | 440.3 | 480.4 | 465.5 | 490.8 |
| Total Current Liabilities | 2885.6 | 3078.5 | 2522.3 | 2642.9 | 2641.5 |
| Accounts Payable | 880.7 | 934.8 | 765.5 | 754.7 | 623.6 |
| Accrued Expenses | 1110.7 | 1254.3 | 1218.9 | 1331.9 | 1449.9 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 307.5 | 307.3 | 7 | 12.1 | 12 |
| Other Current Liabilities, Total | 586.7 | 582.1 | 530.9 | 544.2 | 556 |
| Total Liabilities | 9858.5 | 10058.5 | 9733.8 | 10002.4 | 10007.3 |
| Total Long Term Debt | 5134.3 | 5122.4 | 5420.1 | 5442.2 | 5466.5 |
| Long Term Debt | 5052.3 | 5038.8 | 5334.3 | 5360.3 | 5383.3 |
| Capital Lease Obligations | 82 | 83.6 | 85.8 | 81.9 | 83.2 |
| Deferred Income Tax | 737.4 | 736.2 | 672.7 | 743.4 | 765.2 |
| Minority Interest | 19.3 | 18.9 | 18.9 | 20 | 20.6 |
| Other Liabilities, Total | 1081.9 | 1102.5 | 1099.8 | 1153.9 | 1113.5 |
| Total Equity | 10341.5 | 10096.6 | 10092.2 | 10400.7 | 10721.1 |
| Common Stock | 8.1 | 8.1 | 8.2 | 8.3 | 8.5 |
| Additional Paid-In Capital | 47.7 | 0 | 0 | 29.1 | |
| Retained Earnings (Accumulated Deficit) | 10729.9 | 10581.7 | 10845 | 10897.9 | 10948.4 |
| Other Equity, Total | -444.2 | -493.2 | -761 | -505.5 | -264.9 |
| Total Liabilities & Shareholders’ Equity | 20200 | 20155.1 | 19826 | 20403.1 | 20728.4 |
| Total Common Shares Outstanding | 88.6 | 88.2 | 89.6 | 91 | 92.9 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1280.6 | 2379.5 | 1557 | 824.9 | 883.9 |
| Cash From Operating Activities | 1955.9 | 3109.6 | 2135.3 | 1444.7 | 1305.4 |
| Cash From Operating Activities | 633.9 | 745.1 | 624.7 | 577.2 | 552.1 |
| Deferred Taxes | 18.3 | -75.9 | -47 | 29.2 | 22.2 |
| Non-Cash Items | 626.5 | 324.6 | 857.5 | 307.8 | -82.5 |
| Cash Taxes Paid | 504.7 | 1000 | 500 | 216.8 | 349.7 |
| Cash Interest Paid | 197.1 | 194.7 | 216.6 | 248.9 | 296.2 |
| Changes in Working Capital | -603.4 | -263.7 | -856.9 | -294.4 | -70.3 |
| Cash From Investing Activities | -1652.2 | -884.6 | -643.2 | -1283.1 | 206.7 |
| Capital Expenditures | -481.9 | -460.4 | -381.7 | -400.2 | -379.8 |
| Other Investing Cash Flow Items, Total | -1170.3 | -424.2 | -261.5 | -882.9 | 586.5 |
| Cash From Financing Activities | -1322.2 | -2065.8 | -517.4 | -252.7 | -1389.9 |
| Financing Cash Flow Items | -77.6 | -74 | -61.1 | -77.5 | -54.4 |
| Issuance (Retirement) of Stock, Net | -1049.4 | -1616.8 | -44.1 | -385.3 | -630.9 |
| Issuance (Retirement) of Debt, Net | 0 | -375 | -412.2 | 210.1 | -704.6 |
| Foreign Exchange Effects | -24.2 | -7.3 | 8.6 | 1.8 | -12 |
| Net Change in Cash | -1042.7 | 151.9 | 983.3 | -89.3 | 110.2 |
| Total Cash Dividends Paid | -195.2 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 213.3 | 1280.6 | 1204.2 | 851 | 492.1 |
| Cash From Operating Activities | 121.2 | 1955.9 | 1302.3 | 928.5 | 356 |
| Cash From Operating Activities | 165.9 | 633.9 | 477.7 | 320.6 | 161.5 |
| Deferred Taxes | 1.8 | 18.3 | -51.6 | -35.5 | -19 |
| Non-Cash Items | 96.4 | 626.5 | 255.9 | 180.2 | 84.7 |
| Cash Taxes Paid | 33 | 504.7 | 422.5 | 291.5 | 28.9 |
| Cash Interest Paid | 70.4 | 197.1 | 159.4 | 46.7 | 20.6 |
| Changes in Working Capital | -356.2 | -603.4 | -583.9 | -387.8 | -363.3 |
| Cash From Investing Activities | -99.7 | -1652.2 | -1378.9 | -815.6 | -573.1 |
| Capital Expenditures | -93.9 | -481.9 | -364 | -260.5 | -117.2 |
| Other Investing Cash Flow Items, Total | -5.8 | -1170.3 | -1014.9 | -555.1 | -455.9 |
| Cash From Financing Activities | -60.6 | -1322.2 | -949.6 | -497.4 | -17.7 |
| Financing Cash Flow Items | -23.8 | -77.6 | -68.6 | -49.8 | -35.9 |
| Issuance (Retirement) of Stock, Net | 27.6 | -1049.4 | -749.4 | -380.9 | 18.2 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | 0 |
| Foreign Exchange Effects | 3 | -24.2 | -36.6 | -19.4 | -4.4 |
| Net Change in Cash | -36.1 | -1042.7 | -1062.8 | -403.9 | -239.2 |
| Total Cash Dividends Paid | -64.4 | -195.2 | -131.6 | -66.7 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.6076 | 10284344 | -86991 | 2023-06-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.7903 | 5130213 | -91444 | 2023-06-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4363 | 3930572 | -3793 | 2023-06-30 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 4.0369 | 3576732 | 643059 | 2023-06-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.3278 | 2062422 | -638912 | 2023-06-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.1175 | 1876144 | 33093 | 2023-06-30 | LOW |
| Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 1.951 | 1728619 | -43798 | 2023-06-30 | LOW |
| BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 1.8031 | 1597531 | 115410 | 2023-06-30 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.648 | 1460170 | -16339 | 2023-06-30 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.4127 | 1251644 | -50061 | 2023-06-30 | LOW |
| Southpoint Capital Advisors LP | Hedge Fund | 1.1621 | 1029579 | 429579 | 2023-06-30 | HIGH |
| Fidelity Management & Research Company LLC | Investment Advisor | 1.0564 | 935963 | 92038 | 2023-06-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0508 | 931016 | 47932 | 2022-12-31 | LOW |
| Nuveen LLC | Pension Fund | 1.0393 | 920835 | 553701 | 2023-06-30 | LOW |
| Veritas Investment Partners (UK) Limited | Investment Advisor | 0.9697 | 859171 | 2872 | 2023-06-30 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.9586 | 849344 | 131677 | 2023-06-30 | LOW |
| Managed Account Advisors LLC | Investment Advisor | 0.9422 | 834800 | -39540 | 2023-06-30 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.9246 | 819202 | -34063 | 2023-06-30 | LOW |
| American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9242 | 818840 | 43511 | 2023-06-30 | LOW |
| Nordea Funds Oy | Investment Advisor | 0.8374 | 741968 | -67388 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Laboratory Company profile
About Laboratory Corp. of America Holdings
Laboratory Corporation of America Holdings is a life sciences company that provides clinical laboratory and end-to-end drug development services. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The Company also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The Company serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. It also helps in delivering non-clinical testing services.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Laboratory Corp. of America Holdings revenues increased 15% to $16.12B. Net income increased 53% to $2.38B. Revenues reflect DX segment increase of 12% to $10.36B, DD segment increase of 20% to $5.85B, Northern America segment increase of 14% to $13.09B, Europe segment increase of 36% to $2.05B, Other Countries segment increase of 4% to $976.4M.
Equity composition
Common Stock $.10 Par, 3/11, 265M, 122,400,000 issd., less treasury 22,200,000 @ $937.6M. Insiders own 0.25%. PO 5/91, 40M shares @ $17.875 byFirst Boston. 5/02,6/01, 2-for-1 stock splits; 5/00, 1-for-10 reverse stock split. *7/02, Company acquired Dynacare, Inc.
| Industry: | Healthcare Facilities & Services (NEC) |
358 S Main St
BURLINGTON
NORTH CAROLINA 27215-5837
US
Income Statement
- Annual
- Quarterly
News
How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com